Navigation Links
Phase 1 Trial of Whole-Parasite Malaria Vaccine to Begin
Date:4/22/2009

eams at the Center for Vaccine Development and the Naval Medical Research Center -- findings that were never translated into a vaccine development effort because the task was considered to be impossible."

Sanaria Inc. was founded in 2003. The company's primary mission is to develop and commercialize a malaria sporozoite vaccine against Plasmodium falciparum, the parasite responsible for more than 95 percent of malaria-associated severe illness and death world-wide, and the malaria parasite for which there is the most significant drug resistance. Sanaria has overcome the initial technological and regulatory barriers with support from many partners and colleagues, including those at the National Institute of Allergy and Infectious Diseases, the US Military Malaria Vaccine Program, the US Army Military Infectious Diseases Research Program, the Institute for One World Health, the PATH Malaria Vaccine Initiative, and the University of Maryland School of Medicine Center for Vaccine Development. Sanaria's facilities are in Rockville, MD. For more information, see www.sanaria.com.

Except for historical information, this news release contains certain forward-looking statements that involve known and unknown risk and uncertainties, which may cause actual results to differ materially from any future results, performance or achievements expressed or implied by the statements made. Such statements include the assessment of the vaccine candidate, expectations for the number and timing of the inoculation of study subjects, the expectations for immunity of the vaccine, and belief concerning the measure of success. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include, without limitation, the Company's ability to raise sufficient fund
'/>"/>

SOURCE Sanaria Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
2. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
3. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
4. Circassias Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients
5. Elusys Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study
6. Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
7. VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis
8. Novagali Pharma Completed a New Phase II With Cyclokat(R) in Dry Eye
9. Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimers Disease
10. Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
11. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... This report analyzes the worldwide markets for Enteral ... Enteral Feeding Pumps, Nasogastric Tubes, and Others. The ... Japan , Europe , ... and Rest of World. Annual estimates and forecasts are provided ... analysis is provided for these markets. The report ...
(Date:9/30/2014)... , Sept. 30, 2014  Hologic, Inc. (NASDAQ: ... MacMillan , Hologic,s President and Chief Executive Officer, will ... on October 1, the first day of Breast Cancer ... the Company,s campaign focused on the important benefits of ... by the FDA as clinically superior to traditional mammography. ...
(Date:9/30/2014)... ROCKVILLE, Md. , Sept. 30, 2014 /PRNewswire/ ... natural way to modernize medicine, announced today the ... line of nutraceuticals developed to address men and ... staying healthy and vibrant into old age while ... line includes three condition-specific, whole-food and herb-based formulas, ...
Breaking Medicine Technology:Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3
... Md., March 20, 2012   Sunpeaks Ventures, Inc. ... "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare ... that Clotamin® will soon be available at Navarro ... Founded in 1940, Navarro Discount Pharmacies, Inc. is ...
... FARMINGTON, Conn., March 20, 2012 /PRNewswire-iReach/ -- ... 3 significant Biotech and Healthcare conferences scheduled for Boston, MA ... Annual mHealth World Congress July 25-27, ... in the healthcare industry from the way consumers engage in ...
Cached Medicine Technology:Sunpeaks Ventures Announces Clotamin to be Sold at Navarro Discount Pharmacies 2Annual Biotech and Healthcare Conferences Being Held in Boston MA, Summer 2012 2Annual Biotech and Healthcare Conferences Being Held in Boston MA, Summer 2012 3
(Date:9/30/2014)... UC Irvine immunologists reveals new information about how our ... that determines how the body,s ability to fight infection ... Immunology , neurology professor Dr. Michael Demetriou, postdoctoral scholar ... a critical mechanism underlying how T cells are created, ... cell is a type of blood cell called a ...
(Date:9/30/2014)... September 30, 2014 Glycodrive , ... Nutraceuticals designed to help maximize lean, strong muscle growth ... body’s absorption of glucose has caught the attention of ... main purpose behind Glycodrive is to help the body ... reports Michaels. “Carbs are essential in the muscle-building process, ...
(Date:9/30/2014)... Vegas, NV (PRWEB) September 30, 2014 ... is helping people perform better in and out of the ... and memory has caught the attention of Shane Michaels, prompting ... day-to-day grind, fatigue is the reason most people simply just ... whether that means staying focused at work, getting the motivation ...
(Date:9/30/2014)... 2014 For most families, fall means ... pumpkin patch or annual festival. For millions of children, ... like the respiratory infection Enterovirus D68. , While ... small percentage – especially children with weakened immune systems ... the Enterovirus is prompting hospitals across the country to ...
(Date:9/30/2014)... Regenerative Medicine Solutions (RMS) is set ... Nashville, Tennessee. RMS welcomes the launch of an entirely ... of a new treatment center for the Lung Institute. ... Institute to Nashville, the hope is to bring awareness ... diagnosed and undiagnosed. With Nashville being a hub for ...
Breaking Medicine News(10 mins):Health News:UCI study uncovers important process for immune system development 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:As Hospitals Combat Enterovirus Outbreaks, Patients and Families Turn to “Virtual Visits” with CaringBridge 2Health News:Regenerative Medicine Solutions Expanding 2
... LAUDERDALE, Fla., June 23 MEDmarketplace.com announced ... MedAssets Supply Chain Systems, effective June 1, 2009. ... buying and selling of unused and excess medical equipment. ... customers, including 1,800 hospital and IDN facilities and non ...
... But for those suffering from stress, money trouble or chronic ... find. Now, a Tel Aviv University researcher says we should ... Tel Aviv University,s Sackler School of Medicine is engaged in ... of happiness," which may be 50% responsible for an optimistic ...
... Senate Hearing, and Urge Legislators To Request Fund Research , ... throughout the U.S. with type 1 diabetes are in Washington, D.C. ... They,ll be joined by JDRF International Chairman Mary Tyler ... platinum group The Jonas Brothers, boxing legend Sugar Ray Leonard ...
... avoid dreaded "doughnut hole" , , WASHINGTON, June 23 ... million older Americans will have fallen into the "doughnut hole"--a ... on the hook for all of their own drug costs ... online resource to help older Americans avoid this dreaded coverage ...
... giving the Food and Drug Administration (FDA) the power to ... House ceremony today. , , (Logo: ... government can now regulate the amount of nicotine in tobacco ... detailed on the label and prohibit deceptive marketing and ads ...
... most frequent congenital abnormality of the small bowel and ... asymptomatic but approximately 4% are symptomatic with complications such ... al presents a case of Meckel,s diverticulum masked by ... foundings will be published on June 14, 2009 in ...
Cached Medicine News:Health News:MedAssets Awards MEDmarketplace.com Contract for Idle Capital Equipment, Hospital Equipment and Supplies 2Health News:In pursuit of a happiness gene 2Health News:150 Children, Celebrities With Type 1 Diabetes Converge on Capitol Hill for JDRF's Children's Congress 2009 2Health News:150 Children, Celebrities With Type 1 Diabetes Converge on Capitol Hill for JDRF's Children's Congress 2009 3Health News:150 Children, Celebrities With Type 1 Diabetes Converge on Capitol Hill for JDRF's Children's Congress 2009 4Health News:AARP Launches Money-Saving Prescription Drug Resource 2Health News:AARP Launches Money-Saving Prescription Drug Resource 3Health News:Lung Cancer Alliance Hails Signing of Tobacco Control Legislation Into Law; Urges Action on Lung Cancer 2
... is a suture option for ... diameter looped FiberWire products allow ... extensor tendon repairs while reducing ... passes. FiberLoop is available with ...
... study remains the mainstay in a urologic workup. ... patient needs for an accurate, easy-to-use in-office uroflow ... onset of urine flow and automatically ends when ... urine flow. There is no need to have ...
UroPass Open Tip Ureteral Stents perfect over-the-wire placement with a combination of flexibility and rigidity for comfort and control. When it comes to stent designs, UroPass is a proven leader....
... Ureteral Stents feature teardrop shaped kidney curls ... hydrophilic coating for ease of placement, and ... the trigone. The Multi-Flex advanced design has ... segment provides pushability for placement, and strength ...
Medicine Products: